BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37815735)

  • 41. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
    Choi H; Ahn H; Lee R; Cho SY; Lee DG
    Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years.
    Haddad S; Jabbour JF; Hindy JR; Makki M; Sabbagh A; Nayfeh M; Boustany M; El-Zein S; Tamim H; Zakhem AE; El Cheikh J; Bazarbachi A; Kanj SS
    J Glob Antimicrob Resist; 2021 Dec; 27():228-235. PubMed ID: 34607062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
    Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
    BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
    Poutsiaka DD; Skiffington S; Miller KB; Hadley S; Snydman DR
    J Infect; 2007 Jun; 54(6):567-71. PubMed ID: 17188750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
    Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
    Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterising health care-associated bloodstream infections in public hospitals in Queensland, 2008-2012.
    Si D; Runnegar N; Marquess J; Rajmokan M; Playford EG
    Med J Aust; 2016 Apr; 204(7):276. PubMed ID: 27078605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
    Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
    Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
    J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
    Biedenbach DJ; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
    Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
    Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases.
    Liu LP; Lin QS; Yang WY; Chen XJ; Liu F; Chen X; Ren YY; Ruan M; Chen YM; Zhang L; Zou Y; Guo Y; Zhu XF
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):66. PubMed ID: 37422680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changing epidemiology of bloodstream infection pathogens over time in adult non-specialty patients at an Australian tertiary hospital.
    Aung AK; Skinner MJ; Lee FJ; Cheng AC
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E333-41. PubMed ID: 23330707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital.
    Sajedi Moghaddam S; Mamishi S; Pourakbari B; Mahmoudi S
    BMC Infect Dis; 2024 Apr; 24(1):373. PubMed ID: 38565980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan.
    Lai HP; Hsueh PR; Chen YC; Lee PI; Lu CY; Lu MY; Lin WC; Hsieh YC; Lee CY; Lin KH; Huang LM
    J Microbiol Immunol Infect; 2003 Sep; 36(3):197-202. PubMed ID: 14582565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.